medigraphic.com
ISSN 0185-3325 (Print)
Órgano Oficial del Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz

2005, Number 4

<< Back Next >>

Salud Mental 2005; 28 (4)

Psychosocial functioning of schizophrenic patients according to their alcohol consumption.

Villamil SV, Valencia CM, Díaz MLR, Medina-Mora IME, Juárez F

Language: Spanish
References: 45
Page: 40-48
PDF size: 85.49 Kb.


ABSTRACT

Background: Between 1% and 1.5% of the world population is affected by schizophrenia. In Mexico, it has been estimated that between 619,550 and 1,239,101 (1-2%) individuals suffered from schizophrenia in 2000. The condition is more common among male teenagers and young adults. The main features of schizophrenia are the positive and negative symptoms closely associated with a psychosocial functioning impairment. In addition, between 25% and 80% of the psychiatric population uses addictive substances, with alcohol, at 50%, being one of the most highly used. These substances use is closely associated with a poor psychosocial functioning; when alcohol use is accompanied by schizophrenia, psychosocial functioning is even more disrupted. In the last few years, it has been shown that an early reinsertion of schizophrenic individuals into their social and familial environment causes a lesser degree of impairment in their psychosocial functioning. This functioning is evaluated through the acquisition of new skills to move about in familial, social and work environments. The latter is called psychosocial treatment. In this sense, psychosocial functioning is described as each individual’s ability to adapt, function, move about and interact in a social and personal environment. This functioning evaluates the social, occupational, economic, sexual and familial areas.
Objective: The objective of this study was to establish the association between schizophrenic patients’ psychosocial functioning according to their alcohol use and the severity of schizophrenia.
Methodology: Eighty schizophrenic, psychiatrically stable, subjects were selected during a 14-month period of time. All of them were submitted only once to the Psychosocial Functioning Scale (PFS), the Composite International Diagnostic Interview (CIDI), the Positive and Negative Symptoms Scale (PANSS) and the Alcohol Use Disorders Identification Test (AUDIT). These scales were used in order to confirm the schizophrenia diagnostic and its severity, to measure the psychosocial functioning of this population, to identify early on problems related to alcohol use and to perform an alcohol use/dependency diagnostic on those individuals who met such diagnostic criteria. A Chi squared, Mann-Whitney’s U, the t test, Kruskal-Wallis and the one-way ANOVA were used for statistical analysis purposes.
Results: Seventy-one percent of the subjects were males and 29% females; 87% were single and 70% were unemployed or had an informal job. Thirty-one years was the average age among males and 34 among females. Subjects started suffering schizophrenia when they were between 12 and 30 years (average: 23 years; SD: 6.36), and 94% of them started using alcohol while they were at this very same age range (average: 20 years; SD: 4.98). Seventy-six percent of the subjects presented a schizophrenia evolution of less than ten years. Comparing alcohol use with psychosocial functioning according to the AUDIT, the social and familial were the more affected areas, both of which showed statistically significant differences. As to the period of evolution of schizophrenia and psychosocial functioning, the 16-20 year group was the one which showed less satisfaction. Schizophrenia severity did not show any statistical significance when compared to the type of alcohol use.
Conclusion: Results from this research are similar to those from other Mexican and international studies which have found out that schizophrenia onset is more common during teenage, that more men than women are affected by the condition and that most subjects suffer it first when they are between 16 and 25 years. On the other hand, it has been found out that alcohol use is starting at increasingly early ages, with men being the main users. Such an association has lead many researchers to think that schizophrenia onset is highly associated with alcohol use, be it because the negative symptoms of schizophrenia promote the initial use of alcohol or because alcohol use triggers the early onset of schizophrenia.
In this study it was not possible to prove such an hypothesis given the reduced number of subjects in the sample. This was not either the main objective of the study and given the fact that some other type of methodology is required to identify such an association. However, it is clear that there is a high non-diagnosed comorbidity between schizophrenia and alcohol use which, as a result, is not treated and translates, ultimately, into a bigger impairment of the psychosocial functioning. Among the scales employed, AUDIT is an excellent screening instrument to detect subjects at risk of becoming alcoholics and to identify incipient alcohol use patterns and the problems associated with it. Thus, it is suggested that it could be used both in first and third level hospitals. Finally, although no statistically significant results were found out in any of the variables, there is enough evidence where the association between schizophrenia and alcohol leads to an accumulated effect influencing the psychosocial functioning impairment. In the light of this, it is suggested that clinicians inquire about alcohol use in patients showing some mental pathology to research more in depth the schizophrenia-alcohol comorbidity phenomenon and its association with psychosocial functioning so as to design adequate prevention, treatment and rehabilitation programs for the schizophrenic population.


REFERENCES

  1. 1. ASOCIACION PSIQUIATRICA AMERICANA: Manual Diagnóstico y Estadístico de los Trastornos Mentales. Cuarta edición (DSM-IV). Editorial Masson SA, Barcelona, 1995.

  2. 2. BELL JM, MILSTEIN R, BEAM-GOULET J y cols.: The Positive and Negative Syndrome Scale and the Brief Psychiatric Rating Scale. Reliability, comparability and predictive validity. J Nerv Ment Dis, 180:723-728, 1992.

  3. 3. BOJHORLM S, STRÖMGREN E: Prevalence of schizophrenia on the island of Bornholm in 1935 and in 1983. Acta Psychiatr Scand, 79(supl, 348):157-166, 1989.

  4. 4. BORGES G: Detección de problemas relacionados con el alcohol en salas de emergencia. Pachuca, Hidalgo, México. Instituto Mexicano de Psiquiatría, México, 1997.

  5. 5. CARAVEO J: La prevalencia de los trastornos psiquiátricos en la población mexicana. Estado actual y perspectivas. Salud Mental, 19(Supl. abril):8-13, 1996.

  6. 6. CRAWFORD V: Comorbidity of substance misuse and psychiatric disorders. Current Opinion Psychiatry, 9:231-234, 1996.

  7. 7. DE LA FUENTE JR, KERSENOBICH D: El alcoholismo como problema médico. Revista Facultad Medicina, 35:47-51, 1992.

  8. 8. DE LA FUENTE R, MEDINA-MORA ME, CARAVEO J: Salud Mental en México. Fondo de Cultura Económica, México, 1997.

  9. 9. DESJARLAIS R, EISENBERG L, GOOD B, KLEINMAN A: Problems and Priorities in Low-income Countries. University Press, Nueva York, Oxford, 1995.

  10. 10. DIAZ LR, OSORNIO A, DIAZ A y cols.: La Salud Mental en el Municipio de Querétaro: Estudio Epidemiológico de la Población Marginada. Querétaro, México, Sociedad de Salud Mental del Estado de Querétaro, 1994.

  11. 11. DIAZ LR: Comorbilidad psiquiátrica: Consumo excesivo de alcohol y trastornos psiquiátricos. En: Las Adicciones: Hacia un Enfoque Multidisciplinario. CONADIC, 100-105, México, 1994.

  12. 12. DIAZ LR, MUROW E, ORTEGA H y cols.: El manejo integral del paciente esquizofrénico. Un modelo del Instituto Mexicano de Psiquiatría. Salud Mental, 19(4):1-7, 1996.

  13. 13. DIAZ LR, RASCON ML, VALENCIA M y cols.: El programa de rehabilitación integral del paciente esquizofrénico del Instituto Mexicano de Psiquiatría. Seguimiento a 2 años. Salud Mental, 22(número especial):104-113, 1999.

  14. 14. DIXON L: Dual diagnosis of substance abuse in schizophrenia: prevalence and impact on outcomes. Schizophr Res, 35(Supl):93-100, 1999.

  15. 15. FLORES DL, RUIZ E: Evaluación de la incapacidad relacionada al consumo de alcohol en pacientes que recibieron tratamiento integral hospitalario. Tesis para obtener la licenciatura en psicología. Facultad de psicología. Universidad Nacional Autónoma de México. 1984.

  16. 16. GUEVARA-ARNAL L, ZAPATA L, KAPLAN M y cols.: Excessive alcohol intake among Mexican patients. J Addict, 2:170-176, 1995.

  17. 17. HAMBRECHT M, HÄFNER H: Substance abuse and the onset of schizophrenia. Biol Psychiatry, 40:1155-1163, 1996.

  18. 18. HERRERA M, TORNER C, GONZALES G y col.: Estudio de confiabilidad de la traducción al español de la Escala de Síntomas Positivos y Negativos (PANSS) para valorar esquizofrenia. Psiquis, 2(2):47-51, 1993.

  19. 19. KAY SR, FISZBEIN A, OPLER LA: The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull, 13(2):261-276, 1987.

  20. 20. KAY SR, OPLER LA, LINDENRNAYER JP: Reliability and validity of the positive and negative syndrome scale for schizophrenia. Psychiatry Res, 23:99-110, 1988.

  21. 21. KHANTZIAN EJ: The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence. Am J Psychiatry, 142(11):1259-1264, 1985.

  22. 22. MEDINA-MORA ME, BERENZON S, LOPEZ EK y cols.: El uso de los servicios de salud por los pacientes con trastornos mentales: resultados de una encuesta en una población de escasos recursos. Salud Mental, 20(Supl. 2):32-38, 1997.

  23. 23. MEDINA-MORA MA, CARREÑO S, DE LA FUENTE JR: Experience with the Alcohol Use Disorders Identification Test (AUDIT) in México. En: Recent Developments in Alcoholism, Volume 14: The Consequences of Alcoholism. Galanter (ed.). Plenum Press, Nueva York, 1998.

  24. 24. MEDINA-MORA MA, BORGES G, LARA C y cols.: Prevalencia de trastornos mentales y uso de servicios: Resultados de la Encuesta Nacional de Epidemiología Psiquiátrica en México. Salud Mental, 26(4):1-16, 2003.

  25. 25. MILLER NS, ERIKSEN A, OWLEY T: Psychosis and schizophrenia in alcohol and drug dependence. Psychiatr Ann, 24:418-423, 1994.

  26. 26. ORGANIZACION MUNDIAL DE LA SALUD: Programa sobre abuso de sustancias. AUDIT: Prueba de Identificación de Trastornos Derivados del Consumo de Alcohol: Pautas de uso en la Atención Primaria de la Salud. OMS/PAS/92.4. Ginebra, 1992.

  27. 27. PEÑA MP: Consumo de Alcohol en Pacientes del IMSS. Consejo Nacional de Lucha contra las Adicciones CONADIC, México, 1996.

  28. 28. RASCON ML, ARREDONDO A, TIRADO L y cols.: Una aproximación al costo del tratamiento de las enfermedades mentales en México: depresión y esquizofrenia. Salud Mental, 21(1):43-47, 1998.

  29. 29. ROBINS LN, WITTCHEN HU, HELZER JE y cols.: The Composite International Diagnostic Interview. An epidemiologic instrument suitable for use in different cultures. Arch Gen Psychiatry, 45:1069-1077, 1988.

  30. 30. ROJAS E, FLEIZ C, MEDINA-MORA ME y cols.: Consumo de alcohol y drogas en estudiantes de Pachuca, Hidalgo. Salud Pública México, 41(4):297-308, 1999.

  31. 31. SANDOVAL X: Depresión, ansiedad, memoria y funcionamiento psicosocial en pacientes sometidos a revascularización coronaria. Tesis para obtener el grado de maestro en Ciencias Médicas. Universidad Nacional Autónoma de México, 1998.

  32. 32. SECRETARIA DE SALUD: Encuesta Nacional de Adicciones. Tomo I-II. Alcohol. México, 1998.

  33. 33. VALENCIA M: Criterios metodológicos para diseñar instrumentos de investigación: La Escala de Funcionamiento Psicosocial. La Psicología Social en México. Volumen I. Editorial Asociación Mexicana de Psicología Social, México, 1986.

  34. 34. VALENCIA M, ROJAS E, GONZALEZ C y cols.: Evaluación del funcionamiento psicosocial en pacientes de un centro de salud. Salud Pública México, 31:674-687, 1989.

  35. 35. VALENCIA M: Manejo psicosocial del paciente esquizofrénico. Psiquiatría, 12(3):72-86, 1996.

  36. 36. VALENCIA M, SALDIVAR G, RIVERA E: Funcionamiento psicosocial en pacientes con esquizofrenia: treinta meses de seguimiento comunitario. Salud Pública México, 20(2):28-37, 1997.

  37. 37. VALENCIA M, RASCON ML: Abordaje psicoterapéutico de la esquizofrenia en pacientes agudos y crónicos. Psicología Iberoamericana, 6(4):18-33, 1998.

  38. 38. VALENCIA M: Programa de intervención psicosocial para pacientes esquizofrénicos crónicos. Salud Mental, 22:128-137, 1999.

  39. 39. VALENCIA M, RASCON ML, ORTEGA-SOTO HA: Capítulo X. El tratamiento psicosocial en los pacientes con esquizofrenia. En: Ortega-Soto H, Valencia-Collazos M (eds.). Esquizofrenia. Estado Actual y Perspectivas. Publicaciones del Instituto Nacional de Psiquiatría Ramón de la Fuente. México, 2001.

  40. 40. VALENCIA M: Capítulo XIII. El manejo comunitario de la esquizofrenia. En: Ortega-Soto H, Valencia-Collazos M (eds.). Esquizofrenia. Estado Actual y Perspectivas. Publicaciones del Instituto Nacional de Psiquiatría Ramón de la Fuente. México, 2001.

  41. 41. VALENCIA M, LARA MC, RASCON ML: La importancia de los tratamientos farmacológico y psicosocial de los pacientes con esquizofrenia. Revista Latinoamericana Psiquiatría, 2(1):6-21, 2002.

  42. 42. VILLAMIL V: Funcionamiento psicosocial de pacientes esquizofrénicos de acuerdo a su consumo de alcohol según el AUDIT y el CIDI. Tesis para obtener el grado de Maestro en Ciencias. Universidad Nacional Autónoma de México. 2003.

  43. 43. VILLATORO JA, MEDINA-MORA ME, CARDIEL H y cols.: La situación del consumo de sustancias entre estudiantes de la ciudad de México. Medición otoño de 1997. Salud Mental, 22(2):18-30, 1999.

  44. 44. WITTCHEN HU, ROBINS LN, SARTORIUS N y cols.: Cross-cultural feasibility, reliability and sources of variance of the Composite International Diagnostic Interview (CIDI). Br J Psychiatr, 159:645-653, 1991.

  45. 45. WORLD HEALTH ORGANIZATION: CIDI-CORE Computer Manual for Data Entry and Diagnostic Programs for the Composite International Diagnostic Interview (CIDI). (Version 1.0, Rev 4, 1990). WHO, 1990.




2020     |     www.medigraphic.com